Celestica (NYSE: CLS) holder files notice to sell vested common shares

Rhea-AI Filing Summary

A holder of Celestica Inc. (CLS) common shares filed a notice of intent to sell stock acquired through equity awards. The filing covers common shares to be sold on the NYSE through Canaccord Genuity, including 89,482 shares with an aggregate market value of 25,143,547.18 and 1,062 shares with an aggregate market value of 298,411.38, based on the figures shown. These shares were acquired on 02/02/2026 and 02/04/2026 via performance share unit and restricted share unit vesting from Celestica Inc. Shares outstanding were 115,036,621 common shares as of the data in the filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Canaccord Genuity 40 Temperance Street Suite 2100 Toronto A6 M5H 0B4	89482	25143547.18	115036621	02/02/2026	NYSE
Common Shares	Canaccord Genuity 40 Temperance Street Suite 2100 Toronto A6 M5H 0B4	1062	298411.38	115036621	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	02/02/2026	Performance share unit vesting	Celestica Inc.			85920	02/02/2026	N/A
Common Shares	02/02/2026	Restricted share unit vesting	Celestica Inc.			3562	02/02/2026	N/A
Common Shares	02/04/2026	Restricted share unit vesting	Celestica Inc.			1062	02/04/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CLS Form 144-style notice disclose about Celestica shares?

The notice discloses a planned sale of Celestica Inc. common shares acquired from equity awards. It lists specific share amounts, aggregate market values, the executing broker, the NYSE as the exchange, and total common shares outstanding at 115,036,621.

How many Celestica (CLS) shares are planned for sale in this notice?

The notice lists proposed sales of 89,482 and 1,062 Celestica common shares. Each line item includes the number of shares, aggregate market value, approximate sale date, and confirms the trades are to occur on the NYSE through Canaccord Genuity.

How were the Celestica (CLS) shares in the notice acquired?

The Celestica common shares were acquired through performance share unit vesting and restricted share unit vesting. The filing shows vesting and acquisition dates of 02/02/2026 and 02/04/2026, with Celestica Inc. listed as the source of the awarded shares.

Which broker and exchange are used for the Celestica (CLS) share sales?

The filing identifies Canaccord Genuity, based in Toronto, as the broker handling the trades. The common shares are to be sold on the NYSE, with each line item in the table specifying the NYSE as the securities exchange for the proposed sales.

What market values are associated with the Celestica (CLS) shares to be sold?

For the proposed Celestica common share sales, the notice lists aggregate market values of 25,143,547.18 for 89,482 shares and 298,411.38 for 1,062 shares. These figures represent the total market value corresponding to each share block identified in the table.

What does the filing say about total Celestica (CLS) shares outstanding?

The filing reports 115,036,621 Celestica common shares outstanding in the securities information table. This figure provides context for the size of the proposed sales relative to the company’s overall common share count at the time referenced.